# Implant Direct Sybron Manufacturing LLC – FDA Inspection, Apr 2, 2025

Source: https://www.keypedia.com/records/fda_inspections/implant-direct-sybron-manufacturing-llc/b8fd51e3-336b-48d4-9a47-f3a8bf87268d
Source feed: FDA_Inspections

> FDA inspection 1266772 of Implant Direct Sybron Manufacturing LLC, April 02, 2025. Classification: No Action Indicated (NAI). 9 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1266772
- Company Name: Implant Direct Sybron Manufacturing LLC
- Inspection Date: 2025-04-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1276700 - 2025-07-24
- FDA Inspection 1141791 - 2021-05-12
- [FDA Inspection 1111746 - 2019-12-02](https://www.keypedia.com/records/fda_inspections/implant-direct-sybron-manufacturing-llc/10676b52-ebf1-41ee-8179-cad3c1e6a0f0)
- FDA Inspection 1060206 - 2018-03-27
- FDA Inspection 923088 - 2015-04-21

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dylan-r-jock/a083cb5e-95d7-491d-9c6d-8c36c5963ddf)

Company: https://www.keypedia.com/companies/implant-direct-sybron-manufacturing-llc/56a57268-60f3-4c99-93ba-98bc06bf4f44

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d